VIVOBIOT16.99

Vivo Bio Tech Limited

· Pharma & Health
₹ Crore
Comp Set
In ₹ Crore except Per Share
Latest Annual
VIVOBIOT
FY25
Peer
Median
Valuation — at last close
P/E3.43×
Profitability
EBITDA Margin44.56%
Net Income Margin16.22%
Return on Common Equity9.68%
Return on Capital Employed10.38%
Return on Assets5.36%
Credit & Quality
Total Debt/Equity0.66×
Interest Coverage1.57×
Scale — latest FY
Revenue / Total Income₹46.7 Cr
Net Income₹7.6 Cr
Total Assets₹141 Cr
EPS₹4.95
◆ best value in the comp set per metric · Δ = subject vs median of the other companies.
« ‹ › »Latest: FY25 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 85%.